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Abstract Information on the structures of the oligosaccharides 
linked to Asn residues 159 and 391 of the human complement 
protease Cls  was obtained using mass spectrometric and mono- 
saccharide analyses. Asn ~s9 is linked to a complex-type bianten- 
nary, bisialylated oligosaccharide NeuAc2 Gal2 GIcNAc4 Man3 
(molecular mass = 2206 + 1). Asn 39~ is occupied by either a bian- 
tennary, bisialylated oligosaccharide, or a triantennary, trisialyl- 
ated species NeuAc3 Gal3 GIcNAc5 Man3 (molecular 
mass = 2861-+ 1), or a fucosylated triantennary, trisialylated 
species NeuAc3 Gal3 GIcNAc5 Man3 Fucl (molecular 
mass = 3007 + 1), in relative proportions of approximately 
1:1:1. The carbohydrate _heterogeneity at Asn TM gives rise to 
three major types of C ls  molecules of molecular masses 
79,318 -+ 8 (A), 79,971 -+ 8 (B), and 80,131 -+ 8 (C), with an aver- 
age mass of 79,807 -+ 8. A minor modification, yielding an extra 
mass of 132 _+ 2, is also detected within positions 1-153. 
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1. Introduction 
III) and the ?'-B region (comprising motifs IV, V, and the 
catalytic B chain) [6,7]. The amino acid sequence of human Cls 
has been determined [4,5], indicating that the protein (673 
amino acid residues) contains two N-glycosylation consensus 
sequences (-Asn159-Cys-Ser- and -Asn391-Gly-Ser-). Further 
studies [8] have shown that both positions are occupied by an 
oligosaccharide chain, but that only the carbohydrate linked to 
Asn 159 is susceptible to cleavage by PNGase F. Since early 
carbohydrate analyses performed on intact CTs [9], no precise 
information on the nature of the two N-linked oligosaccharides 
has been obtained. 
Electrospray ionisation MS has proved to be a valuable tech- 
nique for precise mass determination of biopolymers [10,11]. 
The present work is based on the combined use of this tech- 
nique and of monosaccharide analyses performed on Cls or 
various of its fragments and peptides containing one of the two 
oligosaccharides. Our data provide precise information on the 
composition of the oligosaccharides linked to Asn 159 and 
Asn TM, indicating both to be of the complex glycotype, with the 
latter showing three major glycoforms. They also provide indi- 
rect evidence for a minor modification occurring within the 
N-terminal region of Cls. 
The first component of human complement, C1, is a complex 
enzyme comprising two serine proteases, C l r  and Cls, that are 
sequentially activated upon binding of C 1 to various activators 
(for reviews, see [1-3]). Proenzyme Cls, a single-chain protein, 
is converted through cleavage of a single Arg Ile bond into 
C]-s, the active protease responsible for the enzymic activity of 
C1, which contains two disulfide-linked chains A and B. The 
C-terminal B chain is a trypsin-like serine protease domain, 
whereas the N-terminal A chain is a mosaic-like polypeptide 
composed of five structural modules, including two pairs of 
internal repeats (I/III and IV/V) and one epidermal growth 
factor-like motif II [4,5]. The latter contains, at position 134, 
an Asn residue that undergoes partial (approx. 50%) fl-hydrox- 
ylation [6]. The native CTs molecule can be split into two re- 
gions, the c~ region (comprising motifs I, II, and part of motif 
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Abbrev&tions: The nomenclature of complement components is that 
recommended by the World Health Organization; activated compo- 
nents are indicated by an overhead bar, e.g. Cls. ConA, concanavalin 
A; DFP, di-isopropyl phosphorofluoridate; MS, mass spectrometry; 
PNGase F, peptide N-glycosidase F. 
2. Materials and methods 
2.1. Materials 
Human plasmin was obtained from Kabi Vitrum, Stockholm, Swe- 
den. Trypsin (treated with 1-chloro-4-phenyl-3-(L-tosylamido)-butan-2- 
one) was from Sigma. PNGase F was purified from cultures of Fla- 
vobacterium eningosepticum according to the method of Tarentino et 
al. [12], modified as described in [8]. DFP was obtained from Sigma. 
ConA-Sepharose was purchased from Pharmacia, Uppsala, Sweden. 
~-Methyl-D-mannopyranoside was from Janssen Chimica (Noisy le 
Grand, France). 
2.2. Proteins, fragments, and peptides 
CTs was isolated from pooled human plasma s described previously 
[13], and its concentration was estimated from absorbance at280 nm 
by using E(l%,l cm) = 14.5 [7] and an M r value of 79,800, derived from 
the present study. Recombinant human C 1 s was obtained from a bacu- 
lovirus/insect cells expression system, and activated by incubation with 
human Clr as described previously [14]. The ~'-B fragment from both 
human plasma C]s and recombinant Cls was obtained by limited 
proteolysis with plasmin, and the reaction was terminated ineach case 
by blocking the active site serine residues of both ),-B and plasmin with 
DFP, as described in [6]. Both y-B fragments were purified as described 
in [7]. The Cls~ fragment was obtained by limited proteolysis with 
trypsin, and purified as described in [7]. Deglycosylation f Clsc~ with 
PNGase F was carried out as described previously [7]. Peptide ClsA 
154-195 was obtained from CNBr cleavage of fragment Cls 52 [6]. 
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Peptide ClsA 379-422 was obtained from CNBr cleavage of fragment 
T-B and purified as described in [15]. CNBr cleavage was carried out 
with a 30/1 (w/w) CNBr/protein ratio for 24 h at 4°C, either in 70% 
formic acid or in 70% trifluoroacetic acid. 
2.3. Affinity chromatography on ConA-Sepharose 
Fragment Cls 7-B (0,5-1.5 mg), in 50 mM triethanolamine-hydro- 
chloride/145 mM NaC1, pH 7.4, was applied to a ConA-Sepharose 
column (1 x 5 cm) equilibrated with the same buffer. The bound protein 
fraction was eluted by a 5% (w/v) solution of ~-methyl-D-mannopyra- 
noside. Fractions were monitored by absorbance at 280 nm. 
2.4. Monosaccharide analysis 
Samples were dialyzed exhaustively against 0.5% (v/v) acetic acid and 
dried down under vacuum. After methanolysis [16] and trimethylsilyla- 
tion, duplicate analyses of the methylglycosides trimethylsilyl deriva- 
tives were performed by gas-liquid chromatography ona CP Sil 5 CB 
capillary column (0.25 mm x 25 m) [17]. 
2.5. N- Terminal sequence analysis 
N-Terminal sequence analysis of fragment Clsct was performed 
using an Applied Biosystems Model 470 A gas-phase protein sequencer, 
as described previously [7]. 
2.6. Electrospray ionisation MS 
Mass spectra were obtained on an API III triple-quadrupole mass 
spectrometer (PE/Sciex; Thornhill, Ont., Canada) equipped with a neb- 
ulizer-assisted electrospray source (ionspray). A 5 kV voltage was ap- 
plied to the electrospray needle. The mass spectrometer was scanned 
from m/z 1000 to 2000, with steps of 1 m/z unit for proteins, and from 
m/z 700 to 1800, with steps of 0.5 m/z unit for peptides. The dwell time 
was 2 ms and the resolution was one mass unit. For each mass spec- 
trum, 5-10 scans were accumulated in the multiple channel acquisition 
mode. Each molecular species produced a series of multiply charged 
protonated ions. The reconstructed molecular mass profiles were ob- 
e-  
tained using a deconvolution algorithm (PE/Sciex). Horse heart myo- 
globin (16951.5 Da) and insulin (5733.6 Da) were used for calibration. 
Molecular masses are given as isotope-average values. For flow injec- 
tion analyses, samples (80-200 pmol) were dissolved in methanol/water/ 
acetic acid (25:74: 1). The liquid chromatography-MS system com- 
prised a syringe pump Phoenix 20 CU (Carlo Erba Fison Instruments) 
fitted with a homemade capillary column (Nucleosil C8, 0.25 x 150 mm 
fused silica). The flow rate was 5/zl/min, with a linear gradient of 5 90% 
acetonitrile in 0.1% trifluoroacetic acid in 60 min. Proteins and frag- 
ments, dissolved in 6 M urea or triethanolamine-hydrochloride buff rs 
were infused into the column prior to gradient elution, and the solvent 
front containing buffers and salts was bypassed before the column 
effluent was directed to the mass spectrometer. 
3. Results 
3.1. MS analysis of  intact Cls 
The mass spectrum of intact Cls  (Fig. 1) showed a coherent 
series of multiply protonated ions extending from 45 to 60 H ÷. 
Using this series of ions, a complex molecular mass pattern was 
derived, showing three major peaks A, B, and C of molecular 
masses 79,318 + 8, 79,971 + 8, and 80,131 + 8, and two minor 
peaks a and c of masses 79,475 + 8 and 80,272 + 8, respectively. 
Given that about half of the C ls  molecules undergo hydroxyl- 
ation at Asn TM [6], the molecular mass of the polypeptide moi- 
ety of  CTs, calculated from the amino acid sequence, was 
74,888. From the values determined in Fig. 1, the deduced mass 
of the carbohydrate moiety of C]-s ranged from 4430 + 8 (spe- 
cies A) to 5243 + 8 (speciesC). Given the presence of two 
N-linked carbohydrates in Cls, this suggested that species A 
corresponded to molecules with a complex-type biantennary, 
B A 79,971 C 
79,318 I 80,131 
75 
79,500 80,000 11 Molecular Weight 55+1 
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Fig. 1. Electrospray ionisation mass spectrum of intact CTs. The inset represents he reconstructed molecular mass profile derived from the multiply 
charged ions series. The spectrum was obtained as described in section 2. 
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Fig. 2. Schematic representation of the structure of C]s and of the 
various oligosaccharide-containing fra ments and peptides used in this 
study. I, II, III, IV, and V indicate the modules of the N-terminal A
chain, and N the asparagine r sidue at position 134 that undergoes 
partial hydroxylation. The disulfide bridges present in Cls and its ~ and 
y-B fragments are represented. Arrow 1 shows the Arg-Ile bond split 
upon Cls activation, and arrow 2 shows the Arg-Cys bond that is 
partially cleaved in C 1 sm (*) Asn-linked oligosaccharides. (e)Reduced 
and alkylated cysteine residues. 
bisialylated oligosaccharide (expected mas = 2206) at each site, 
whereas the occurrence of the higher molecular weight species 
B and C suggested heterogeneity at one or both site(s). Further 
studies were performed on fragments and peptides containing 
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one of the two carbohydrate attachment sites. These fragments 
and peptides are represented on Fig. 2. 
3.2. MS analysis of fragments containing the oligosaccharide 
linked to Asn s91 
Fragment C]-s y-B, arising from cleavage of the Lys269-Leu 27° 
bond in the A chain [6], contains the oligosaccharide linked to 
Asn 391 (Fig. 2). The molecular mass of its polypeptide moiety 
was calculated to be 44,825, including an extra mass of 164 
accounting for the di-isopropyl phosphate group linked to the 
active site serine (see section 2). The mass spectrum of fragment 
Cls y-B (Fig. 3) showed three major peaks of molecular masses 
47,037 + 5, 47,690 + 5, and 47,834 + 5, present in equivalent 
amounts. The corresponding deduced masses of the carbohy- 
drate moieties of Cls y-B were 2212 + 5, 2865 + 5, and 
3009 + 5, suggesting the occurrence of a complex-type bianten- 
nary, bisialylated oligosaccharide (mass = 2206), a trianten- 
nary, trisialylated oligosaccharide (mass = 2863), and a fucosyl- 
ated triantennary, trisialylated oligosaccharide (mass = 3009). 
In order to discriminate biantennary and triantennary oligo- 
saccharide species, fragment Cls 7-B was loaded on a ConA- 
Sepharose column. The major part of the protein (y-B0 was not 
retained on the column, whereas the rest of the material (y-BII) 
was bound, and then subsequently eluted by s-methyl-o-man- 
nopyranoside. The mass spectrum of y-BI showed two major 
peaks with molecular masses of 47,687 + 5 and 47,838 + 5, 
corresponding to species B and C of Fig. 3, whereas y-Bil 
yielded a single major peak with a mass of 47,037 + 5, corre- 
sponding to species A of Fig. 3. These results were therefore 
consistent with the occurrence at position 391 of three types of 
complex oligosaccharides, namely a biantennary, bisialylated 
31+ 30+ 
28+ 
1200 1300 1400 1500 1600 
m/z 
Fig. 3. Electrospray ionisation mass spectrum of fragment CTs 7-B. 
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species (about 1/3), and a triantennary, trisialylated species, 
either containing or lacking one fucose residue (about 113 each). 
This conclusion was further supported by monosaccharide 
analyses (Table 1), indicating ratios of galactose and N-ace- 
tylglucosamine relative to mannose in ~'-BI and ~'-BH consistent 
with the presence of triantennary and biantennary species, re- 
spectively, and the presence of fucose in )'-Bt. 
Further analyses were performed on peptide ClsA 379422 
(Fig. 2), obtained from CNBr cleavage of fragment ~'-B after 
reduction and alkylation with 4-vinyl pyridine. The calculated 
mass of its polypeptide moiety is 5041.7. The mass spectrum of 
this peptide revealed several peaks, including species of molec- 
ular masses 7247 + 1, 7902 + 1, and 8048 + 1. The deduced 
masses for the oligosaccharide moieties of these species are 
2206 + 1,2861 + 1, and 3007 + 1, corresponding respectively to
the biantennary, triantennary, and fucosylated triantennary 
species already identified (calculated masses -- 2206, 2863, and 
3009, respectively). A species of mass 7612 most likely arose 
from the loss, during CNBr cleavage, of one N-acetylneuram- 
inic acid unit from species 7902 (expected ifference = 291, 
observed = 290). Another species of mass 7572 could not be 
identified. 
Other analyses were performed on fragment ~' and the B 
chain, both reduced and alkylated with iodoacetamide. Frag- 
ment )" yielded three peaks corresponding to the major oligo- 
saccharides described above. In contrast, the B chain yielded 
a single peak of molecular mass 28,112 + 3, consistent with the 
mass deduced from the amino acid sequence (28,100.9, i.e. 
27,936 plus 164 accounting for the di-isopropyl phosphate 
group linked to the active-site serine), providing evidence that 
the B chain undergoes no post-translational modification. 
3.3. MS analysis of the y-B fragment obtained from recombinant 
C7s 
Analysis by MS of the ),-B fragment obtained from recombi- 
nant Cls expressed in the baculovirus/insect cells system 
showed a single major peak with a mass of 45,879 + 5, corre- 
sponding to a deduced mass for the carbohydrate moiety of 
1054 + 5, consistent with a short oligosaccharide structure 
comprising 2 N-acetylglucosamine a d 4 mannose residues (cal- 
culated mass = 1055). 
Table 1 
Analysis of the monosaccharides (residues/mol) f the Cls fragments 
and y-B 
Frag- Fucose Galac- Mannose N-Acetyl- N-acetyl 
ment tose glucosamine neuraminic 
acid 
y-B~ 0.3 _+ 0.1 2.8 + 0.1 3.0 4.6 +_ 0.1 1.2 + 0.2 
y-Bll N.D. 2.0 + 0.1 3.0 3.6 + 0.1 1.1 _+ 0.1 
~z N.D. 2.0 + 0.1 3.0 3.5 + 0.3 1.4 _+ 0.1 
Analyses were performed induplicate on 80-130 pg of each sample, as 
described insection 2. Values are calculated on the basis of 3.0 mannose 
residues/mol, and given as mean values _+ S.D. The low relative con- 
tents in N-acetylneuraminic acid (expected values for ~,-Bl, y-Bn, and 
c~ = 3.0, 2.0, and 2.0, respectively) are most likely due to partial oss 
during dialysis and/or drying of the samples, which were performed 
under acidic conditions (see section 2) known to favour removal of 
sialic acids. The expected relative fucose content of y-BI is 0.5. N.D., 
not detected. 
3.4. MS analysis of fragments containing the oligosaccharide 
linked to Asn 159 
Fragment c~ of Cls extends from positions 1-192 of the A 
chain (Fig. 2). In addition to the oligosaccharide linked to 
Ash 159, approximately half of the C 1 s~ molecules were expected 
to contain fl-hydroxyasparagine at position 134 [6]. Also, it is 
known from previous tudies [7] that partial cleavage of the 
Arg~86-Cys~*V bond occurs during limited proteolysis of CTs 
with trypsin. N-Terminal sequence analysis of the Clsct frag- 
ment used in this study indicated that approx. 56% of the 
molecules were cleaved at this position. 
As shown in Fig. 4A, the mass spectrum of Cls~ showed two 
groups of peaks, centred on mass values of 24,047 + 3 and 
24,181 + 3. The major group contained three observable peaks 
with mass values of 24,031 + 3, 24,047 + 3, and 24,063 + 3. In 
view of the heterogeneities expected at the polypeptide l vel, it 
was hypothesized that the species of molecular mass 24,031 
corresponded to C 1 s~ molecules lacking both hydroxylation at
Asn 134 and internal cleavage (calculated mass of the polypeptide 
moiety = 21,824), the species of mass 24,063 corresponded 
to molecules bearing both modifications (calculated mass = 
21,858), and the intermediary species of mass 24,063 repre- 
sented a mixture of molecules exhibiting either hydroxylation 
or cleavage only (calculated masses 21,840 and 21,842, respec- 
tively). The masses of the carbohydrate moiety deduced for 
each species are 2207 + 3, 2205 +_ 3, 2207 + 3, and 2205 + 3, 
respectively, consistent with the presence on each of the four 
species of a complex-type, biantennary, bisialylated oligosac- 
charide (expected mass--2206). This hypothesis i  in agree- 
ment with monosaccharide analyses performed on fragment 
C 1 s~, which yielded results comparable with those obtained for 
fragment Cls ~'-BII (Table 1). Although the minor group of 
peaks observable in Fig. 4A was poorly resolved, the mass of 
its central component was estimated at 24,181 + 3, i.e. a differ- 
ence of 134 + 3 compared with the intermediate species of the 
major group (molecular mass = 24,047 + 3). Considering that 
both groups of peaks have the same overall shape, the most 
likely hypothesis i  therefore that this double pattern arises 
from another, minor modification occurring in Cls~. 
In agreement with previous data [7,8], treatment ofC 1 s~ with 
PNGase F removed the N-linked oligosaccharide, decreasing 
the mass of the major peaks observed in Fig. 4A by values 
ranging from 2204 to 2206 (Fig. 4B). The molecular mass of the 
lightest species, supposed to contain molecules with no hydrox- 
ylation and no internal cleavage, was estimated at 21,825 + 2, 
in perfect agreement with the predicted value, considering that, 
during cleavage of the oligosaccharide by PNGase F, the Asn 
residue is converted to Asp [8]. The fact that the mass of the 
central component of the minor group also decreased by a 
value of 2205 +_ 2 (Fig. 4A,B) clearly indicated that the putative 
minor modification was independent of the N-linked oligosac- 
charide. Again, after treatment with PNGase F, the difference 
of mass between this minor species and the intermediate species 
of the major group was 131 + 2 (Fig. 4B), in good agreement 
with the value determined from Fig. 4A. 
Further analyses were performed on peptide ClsA 154-195, 
a reduced and S-carboxymethylated CNBr-cleavage peptide 
(Fig. 2). The mass spectrum of this peptide showed a major 
peak with a mass of 7086 + 1, which, by comparison with the 
mass calculated for the peptide moiety (4880.4), yields a de- 
duced mass for the oligosaccharide linked to Asn 159 of 2206 + 1, 
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Fig. 4. Electrospray ionisation mass pectra of fragment Cls~. (A) Native fragment Clsm (B) Fragment Clsc~ treated with PNGase F. 
providing further support o the hypothesis of a biantennary, 
bisialylated oligosaccharide. Two minor peaks of masses 7102 
(+ 16) and 7118 (+32) were also observed, probably arising from 
oxidation of amino acid(s) during CNBr cleavage. No evidence 
for any other modification of the polypeptide backbone was 
obtained, indicating that the putative minor modification 
328 Y Petillot et al./FEBS Letters 358 (1995) 323-328 
occurring in the a region must take place within the N-terminal 
part of this region, more precisely between positions 1and 153. 
4. Discussion 
The analyses performed in this study are consistent with the 
conclusion that: (i) Asn 159 is linked to a complex-type bianten- 
nary, bisialylated oligosaccharide (NeuAc2 Gal2 GlcNAc4 
Man3); (ii) Asn 391 is occupied by either a biantennary, bisialyl- 
ated species, or triantennary, trisialylated species (NeuAc3 
Gal3 GlcNAc5 Man3) containing or lacking a fucose residue. 
The three species attached to msn 391 are present in roughly 
equimolar amounts. Considering that Cls used in this study 
was purified from human plasma pooled from several donors, 
it cannot be concluded whether this heterogeneity occurs in 
each individual or reflects variations from one individual to the 
other. 
This pattern of the N-linked oligosaccharides of Cls allows 
a detailed interpretation of the major peaks observed by MS 
analysis of intact C]-s (Fig. 1). Thus, it appears clearly that: 
(i) species A (molecular mass = 79,318 + 8) contains a bianten- 
nary, bisialylated oligosaccharide at both positions 159 and 391 
(theoretical mass = 79,300); (ii) species B (molecular mass 
79,971 + 8) contains a biantennary oligosaccharide at position 
159, and a non-fucosylated triantennary oligosaccharide at po- 
sition 391 (theoretical mass = 79,957); (iii) species C (molecular 
mass = 80,131 + 8) contains a biantennary oligosaccharide at
position 159, and a fucosylated triantennary species at position 
391 (theoretical mass = 80,103). If one only takes into account 
these species A, B, and C, which represent approx. 75-80% of 
the CTs population, the experimental verage mass of CTs is 
79,807 + 8 (calculated value = 79,787). On the same basis, the 
carbohydrate content of Cls ranges from 5.56% (species A) to 
6.34% (species C), with an average value of 6.13%. 
The MS analyses performed on fragment C 1 sa, together with 
those performed on peptide ClsA 154-195, provide indirect 
evidence for the occurrence of a minor post-translational mod- 
ification taking place within positions 1-153 of C]'s, therefore 
independent of the oligosaccharide linked to Asn 's9. The data 
from Fig. 4A and B, showing minor peaks differing from the 
major species by an extra mass of 134 + 2 and 131 + 2, respec- 
tively, appear consistent with the presence, on about 25% of the 
CTs molecules, of a pentose residue (molecular mass = 132) 
attached to the polypeptide backbone. Considering that Cls 
contains in its N-terminal region (positions 115-160) an epider- 
mal growth factor-like domain, it should be mentioned that 
several cases of O-glycosylation have been reported on serine 
residues located in such domains, e.g. in coagulation Factor IX 
[18-20]. To our knowledge, however, no case of a single O- 
linked pentose residue has ever been described. The hypothesis 
that the extra mass arises from heterogeneity at the sequence 
level appears unlikely, considering that no such heterogeneity 
has ever been detected by sequence analyses performed at the 
cDNA [4,5] or protein [21] levels. Further analyses will be 
required to identify and locate this minor modification. Obvi- 
ously, the minor peaks a and c seen in Fig. 1 can be interpreted 
as derivatives of the major species A and C, respectively, con- 
taining, in addition to the N-linked oligosaccharides, the extra 
modification. It can also be postulated that a third minor peak 
b (expected molecular mass = 80,103), derived from species B, 
occurs at the level of the major species C. 
The MS anal_ysis performed on fragment 7-B obtained from 
recombinant Cls expressed in the baculovirus/insect cells sys- 
tem shows that, in contrast with Cl-s purified from human 
serum, the oligosaccharide linked to Asn TM is homogeneous 
and has a molecular mass consistent with a short high mannose- 
type structure containing 4 mannose and 2 N-acetylglucosam- 
ine residues. This result is in agreement with our previous data 
[14], and consistent with studies performed on recombinant 
HIV-1 gpl20 derived from the same expression system, show- 
ing that all of the N-linked oligosaccharides are of the high 
mannose glycotype [22]. This confirms the limitations of the 
baculovirus-based expression system with respect to the synthe- 
sis of complex-type oligosaccharides. In the case of Cls, 
however, it should be mentioned that the substitution of short 
high-mannose oligosaccharides for complex-type oligosac- 
charides, or even the lack of glycosylation at Asn 159, do not 
significantly impair the functional properties of the protein 
[141. 
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